Research in Medical and Dental Sciences We are dedicated to performing world-leading research with the ultimate goal of improving human health.
Cancer and Genomics Combining anti-tumour drugs with chemo may improve rare children’s cancer outcomes Phase 2 trial found adding Bevacizumab to different chemotherapy drugs led to more patients’ tumours shrinking, which has helped to change routine UK treatment.
Microbiology and Infection New and highly infectious E. coli strain resistant to powerful antibiotics
Applied Health Research Lockdown air quality boost in Oxford helped 41% reduction in adult asthma hospital stays
Immunology and Immunotherapy Immune cells lose ‘killer instinct’ in cancerous tumours – but functionality can be re-awakened
International Research and Engagement Our thriving international community of researchers save and improve lives across the world.
16 February 2022 New study explores unique approach to treat a rare liver disease A UK research study looking into a new approach to treat primary sclerosing cholangitis, a rare disease where the body's immune attacks its own liver.
01 February 2022 Study shows impaired antibody response to COVID-19 vaccination in blood cancer and arthritis patients being treated with widely used drug Certain blood cancer and arthritis patients have a significantly reduced antibody response to double COVID-19 vaccination in the first six months of being treated with a widely used drug, reveals a new study.
31 January 2022 Individuals with immunodeficiency at high risk of mortality following SARS-CoV-2 infection Patients with primary and secondary immunodeficiency are at higher risk of mortality following SARS-CoV-2 infection compared with the general population, according to a new study led by the University of Birmingham.
06 January 2022 Parasitic roundworm poses lung health threat to European men Young men exposed to parasitic roundworm may be at increased risk of developing asthma and serious lung damage, a new study reveals.
04 January 2022 Researchers reveal scale of prevalence of a condition that can cause type 2 diabetes and high blood pressure Scientists are calling for changes to healthcare policy following research showing the scale of the impact of a condition associated with benign tumours that can lead to type 2 diabetes and high blood pressure.